Multiple Myeloma News & Features

Researchers attempt to turn immune cells into unerring killers of multiple myeloma cells

43 percent of study patients with the blood cancer had a complete response, researchers report

WebMD explains what new drugs and treatment techniques are in the pipeline for multiple myeloma, a type of blood cancer.

Response rate doubled for patients with this blood cancer, study finds

Diagnosed with multiple myeloma? WebMD explores how to decide which treatment is best for you.

Diagnosed with multiple myeloma? WebMD shows how you can conquer treatment-related side effects.

Multiple myeloma patients saw survival gains when elotuzumab was added to treatment

Veteran TV journalist has multiple myeloma, which attacks white blood cells in bone marrow

Adding the intravenous bone drug Zometa to chemotherapy improves survival in patients with the blood cancer multiple myeloma, new research from the U.K. shows.

Diana Krall heads up a star-studded charity event aimed at raising money for leukemia research.

The FDA has approved thalidomide -- a drug known to cause severe birth defects -- to help treat newly diagnosed multiple myeloma, a cancer of the bone marrow.

WebMD Asks the Experts About Multiple Myeloma and Thalidomide

Scientists Use Tumor to Fight Tumor in Multiple Myeloma

Thalidomide, a drug notorious for producing birth defects in babies born to women who took it for morning sickness in the 1960s, is proving to be effective for people with advanced multiple myeloma, a cancer of the bone marrow.

Thalidomide, a drug best known for causing horrific birth defects, is prolonging the lives of people with a rare form of cancer, according to a study in The New England Journal of Medicine Thursday.